Evaluation is not just something we do at the end of a program, nor only impact evaluation. Some forms of evaluation are needed at the beginning of new interventions to inform the planning – evaluations in the form of needs analyses, situation analyses (which assess strengths as well as gaps), and reviews of the
Read the whole post –> The Friday Funny: Focusing on the important things in planning major initiatives
Is policy evaluation fundamentally different to program evaluation? How can lessons learned from program evaluation (such as the value of stakeholder involvement) be applied to the evaluation of policies?
The next webinar in the series of monthly live webinars on “Developing national capacities for country M&E systems”, organized by MyMandE” will focus on ‘Evaluation
Read the whole post –> Free webinar on Evaluation and Policies
In the medical profession in particular, there are some very rigid beliefs about what constitutes good enough “evidence of effectiveness” to justify offering, recommending, allowing patients to try, or even just not vehemently opposing a particular type of treatment for a patient. There are some glimmers of hope in other sectors (e.g. in the Best Evidence Synthesis work here in New Zealand). But there are still three areas where there are very serious challenges in building a credible evidence base given the kinds of constraints and realities surrounding them. They are: (1) cutting-edge treatments; (2) treatments that are by their very nature tailored/individualized rather than standardized across patients or populations; and (3) learning what works for small sub-populations
Read the whole post –> What constitutes “evidence”? Implications for cutting-edge, tailored treatments, and small sub-populations